Research Articles | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Young Enough to Undergo Allogeneic Transplantation for Myelodysplastic Syndromes?: Considering the Results of the Medicare Coverage With Evidence Development Study Dec 2019 JAMA Oncology Myelodysplastic Syndromes (MDS)
Wide Variation in Use and Interpretation of Gene Mutation Profiling Panels Among Health Care Providers of Patients With Myelodysplastic Syndromes: Results of a Large Web-Based Survey Jun 2020 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Why Hurry Up and Wait? Transplantation in Lower-Risk Myelodysplastic Syndromes Sep 2020 Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation Myelodysplastic Syndromes (MDS)
Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS Jul 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study Apr 2023 Journal of Hematology & Oncology Myelodysplastic Syndromes (MDS)
Where There's Smoke, There's Fire: Inflammation Drives MDS Jul 2020 Trends in immunology Myelodysplastic Syndromes (MDS)
What causes aplastic anaemia? Apr 2023 Leukemia Aplastic Anemia
What are the most important quality of life domains for patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria? May 2025 Annals of Hematology Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH)
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases Apr 2023 Internal and Emergency Medicine Myelodysplastic Syndromes (MDS)
Venetoclax and Hypomethylating Agents (HMAs) Induce High Response Rates in MDS, Including Patients After HMA Therapy Failure Jul 2020 Blood Advances Myelodysplastic Syndromes (MDS)